<p>A. Probability of <i>in-utero</i> HIV transmission as a function of zidovudine duration; B. Probability of <i>in-utero</i> HIV transmission as a function of viral load at baseline. The lines denote the median, 5<sup>th</sup> and 95<sup>th</sup>percentiles of the model predictions. The open circles stand for the observed mean proportion of transmission, the solid vertical segments denote the corresponding 95% confidence intervals (numbers at top of each segment stand for the number of women in each time interval or VL interval). C. Probability of <i>intra-partum</i> HIV mother-to-child transmission as a function of viral load at delivery without single dose nevirapine; D. Probability of <i>intra-partum</i> HIV mother-to-child transmission...
Introduction: Infants born to women living with HIV initiating combination antiretroviral therapy (...
CONTEXT: A 2-dose intrapartum/newborn nevirapine regimen reduced perinatal human immunodeficiency vi...
Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human im...
BACKGROUND: Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post exp...
Background Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post expo...
HIV transmissions to investigate the preventive role of various antiretroviral treatments intervent...
Peripartum and postpartum probability of HIV transmission by prophylaxis/treatment regimen (%).</p
<p><sup>a</sup>RSE%, relative standard error (standard error of estimate / estimate*100)</p><p><sup>...
<p>*No PMTCT ARVs. **Unspecified ARV regimen. †Single-dose nevirapine if maternal CD4 count >200 cel...
Objective: To evaluate the pharmacokinetics and HIV viral load response following initiation during ...
In a collaboration of 7 European and United States prospective studies, 44 cases of vertical human i...
<p>A) Relative HIV acquisition risk during pregnancy compared to non-pregnant period of the same len...
<p>HIV incidence (with 95% confidence intervals) in women during the period prior to their recruitme...
Replication capacity and transmission of human immuno-deficiency virus (HIV)–1 in antiretroviral dru...
OBJECTIVE: To estimate the effect of maternal factors and events around the time of delivery on HIV-...
Introduction: Infants born to women living with HIV initiating combination antiretroviral therapy (...
CONTEXT: A 2-dose intrapartum/newborn nevirapine regimen reduced perinatal human immunodeficiency vi...
Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human im...
BACKGROUND: Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post exp...
Background Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post expo...
HIV transmissions to investigate the preventive role of various antiretroviral treatments intervent...
Peripartum and postpartum probability of HIV transmission by prophylaxis/treatment regimen (%).</p
<p><sup>a</sup>RSE%, relative standard error (standard error of estimate / estimate*100)</p><p><sup>...
<p>*No PMTCT ARVs. **Unspecified ARV regimen. †Single-dose nevirapine if maternal CD4 count >200 cel...
Objective: To evaluate the pharmacokinetics and HIV viral load response following initiation during ...
In a collaboration of 7 European and United States prospective studies, 44 cases of vertical human i...
<p>A) Relative HIV acquisition risk during pregnancy compared to non-pregnant period of the same len...
<p>HIV incidence (with 95% confidence intervals) in women during the period prior to their recruitme...
Replication capacity and transmission of human immuno-deficiency virus (HIV)–1 in antiretroviral dru...
OBJECTIVE: To estimate the effect of maternal factors and events around the time of delivery on HIV-...
Introduction: Infants born to women living with HIV initiating combination antiretroviral therapy (...
CONTEXT: A 2-dose intrapartum/newborn nevirapine regimen reduced perinatal human immunodeficiency vi...
Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human im...